(Q37769101)

English

A systematic approach to preclinical and clinical safety biomarker qualification incorporating Bradford Hill's principles of causality association

scientific article published on 30 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

A systematic approach to preclinical and clinical safety biomarker qualification incorporating Bradford Hill's principles of causality association (English)

1 reference

Europe PubMed Central

22 August 2017

0 references

author name string

R K Chetty

1

1 reference

Europe PubMed Central

22 August 2017

J S Ozer

2

1 reference

Europe PubMed Central

22 August 2017

A Lanevschi

3

1 reference

Europe PubMed Central

22 August 2017

I Schuppe-Koistinen

4

1 reference

Europe PubMed Central

22 August 2017

D McHale

5

1 reference

Europe PubMed Central

22 August 2017

J S Pears

6

1 reference

Europe PubMed Central

22 August 2017

J Vonderscher

7

1 reference

Europe PubMed Central

22 August 2017

F D Sistare

8

1 reference

Europe PubMed Central

22 August 2017

F Dieterle

9

1 reference

Europe PubMed Central

22 August 2017

language of work or name

0 references

publication date

30 June 2010

1 reference

Europe PubMed Central

22 August 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

22 August 2017

88

1 reference

Europe PubMed Central

22 August 2017

2

1 reference

Europe PubMed Central

22 August 2017

260-262

1 reference

Europe PubMed Central

22 August 2017

Estimation of diagnostic-test sensitivity and specificity through Bayesian modeling

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

An update on FIV and FeLV test performance using a Bayesian statistical approach.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

The Bradford Hill considerations on causality: a counterfactual perspective

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

Renal and retinal effects of enalapril and losartan in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

Towards consensus practices to qualify safety biomarkers for use in early drug development

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

21 January 2018

A prototypical process for creating evidentiary standards for biomarkers and diagnostics

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

7 January 2021

based on heuristic

inferred from DOI database lookup

What is a cause and how do we know one? A grammar for pragmatic epidemiology.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.77

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2010.77

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37769101&oldid=2089641363"